FDA says Fancy Drops Beauty sells unapproved eye drops claimed to change eye color.
What happened
In July 2024, FDA reviewed the Fancy Drops Beauty website and found it offered Fancy Drops Color Changing Solutions Eye Drops in multiple colors for sale in the United States. The website claims said the drops lighten and brighten eye color, change eye color, and inhibit melanin and tyrosinase. FDA determined the products are unapproved new drugs and that no FDA-approved application is in effect for them.
What FDA found
The eye drops are drugs because the website claims they change eye color and affect pigment production.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The products are new drugs because they are not generally recognized as safe and effective for those uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)The products were offered for sale in interstate commerce without an FDA-approved application.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations, explain how recurrence will be prevented, and include supporting documents; if it disagrees, it must give reasoning and evidence.
Who should pay attention
- consumers considering eye-color-changing drops
- retailers and online marketplaces selling eye drops
- brands or importers of ophthalmic products with drug-like claims
This is a summary. Read the original letter on fda.gov.